1992
DOI: 10.1177/106002809202600733
|View full text |Cite
|
Sign up to set email alerts
|

Sucralfate—Warfarin Interaction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1994
1994
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…Therefore, quinolone-metal cation interactions could not only be accounted for by chelate formation. Another mechanism could be adsorption on to antacids or insolubility in neutralized gastric acid [18,19]. However, the systemic availability of DR-3355, the S(-)-enantiomer of ofloxacin, was not influenced by calcium carbonate and oral ranitidine, indicating that changes in gastric pH do not affect the absorption of DR-3355 [6].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, quinolone-metal cation interactions could not only be accounted for by chelate formation. Another mechanism could be adsorption on to antacids or insolubility in neutralized gastric acid [18,19]. However, the systemic availability of DR-3355, the S(-)-enantiomer of ofloxacin, was not influenced by calcium carbonate and oral ranitidine, indicating that changes in gastric pH do not affect the absorption of DR-3355 [6].…”
Section: Discussionmentioning
confidence: 99%
“…Uncontrolled diabetes, advanced kidney diseases, and sensitivity to the drug are the only contraindications for its use. 1,[3][4][5] Even though exact sucralfate in-vivo mechanisms of action remain unknown, in-vitro studies have suggested the seven following mechanisms: 1. inhibition of bacterial activity; 2. reducing oxygen-free radical generation; 3. the effects on arachidonic acid metabolism and increasing prostaglandin release by activating macrophages, cyclooxygenase activity, synthesis, and release of leukotriene C4; 4. decreasing cell apoptosis; 5. enhancing growth factor bioavailability; 6. the effects as a site-protective agent through providing a physical barrier; 7. the effects on tissue growth, regeneration, and repair: facilitating blood flow, cell proliferation, and repair via binding growth factors to tissues 6,7 (Figure 1). In addition to systemic sucralfate, a topical form of drug efficacy has been evaluated in several mucocutaneous indications as clinical and case studies.…”
Section: Introductionmentioning
confidence: 99%